Meta Preps Two New Ray-Ban AI Glasses Models for Prescription Users

Two new Ray-Ban AI glasses models have quietly passed through the Federal Communications Commission this month. The Verge reports the filings reveal devices codenamed "Scriber" and "Blazer," both manufactured by EssilorLuxottica and bearing the Ray-Ban brand. These aren't just incremental updates — Bloomberg AI confirms the new models are specifically designed for prescription wearers, addressing a major gap in the current lineup.

The timing aligns with Meta's broader push into wearable AI. Mark Zuckerberg unveiled the $799 Meta Ray-Ban Display glasses at Meta Connect in September 2025, featuring built-in displays and EMG wristband control. These new models appear to be the next evolution, focusing on prescription compatibility rather than display technology.

Current Ray-Ban Meta glasses work for some prescription users, but the new models appear purpose-built for this segment. According to Bloomberg AI, the design accommodates prescription lenses without the bulk that plagued earlier attempts at smart eyewear.

This matters because prescription wearers represent roughly 64% of adults globally. Previous smart glasses forced users to choose between vision correction and tech features. Meta's approach flips this — the glasses work as regular prescription eyewear first, AI assistant second.

EssilorLuxottica's manufacturing expertise shows here. They're not just slapping tech onto existing frames. The integration appears seamless enough that most observers won't realize these are smart glasses at all.

While full specs remain under wraps, the FCC filings point to enhanced camera capabilities and improved battery life over the current generation. Meta's Newsroom updates from September 2024 highlight upcoming AI features including real-time translation, memory assistance, and visual question answering — all likely included in these new models.

The neural band integration from the $799 Display model probably won't appear here, keeping prices closer to the current $299 range. Instead, expect refined versions of the existing features: better photo quality, longer recording time, and more natural voice interaction.

The "Scriber" codename suggests enhanced note-taking or transcription features, potentially targeting professionals who need hands-free documentation.

Meta's partnership with EssilorLuxottica has already proven successful — the current Ray-Ban Meta glasses sold out repeatedly throughout 2024. These new models directly challenge Apple's Vision Pro approach of separate tech glasses versus prescription needs.

The prescription-first design philosophy could pressure competitors like Google and Amazon to rethink their wearable strategies. Most current smart glasses treat vision correction as an afterthought.

For consumers, this represents the first time they might replace their regular glasses with AI-enhanced versions without compromise. The fashion-forward Ray-Ban styling helps adoption among users who'd never consider bulkier tech eyewear.

Expect official announcements within weeks, likely at a smaller event rather than waiting for Meta Connect 2026. The FCC filings typically precede launches by 4-6 weeks, putting retail availability around late April or early May.

Pricing will be crucial. Current Ray-Ban Meta glasses start at $299. The prescription models will probably command a premium, but Meta needs to stay under $500 to maintain mass-market appeal.

Retail partnerships with LensCrafters, Target Optical, and MyEyeDr suggest widespread availability through existing eyewear channels, not just tech stores. This distribution strategy could prove more effective than traditional consumer electronics launches.

These glasses represent Meta's most consumer-friendly AI product yet. Unlike the Quest headsets or Portal devices, they solve an actual daily problem — needing both vision correction and smartphone features.

The data collection implications are significant. These glasses see what you see, hear what you hear. Meta's privacy policies will face renewed scrutiny, especially after ongoing criticism about their impact on children noted by BBC.

Yet the prescription angle might actually ease privacy concerns. Users already trust optometrists with sensitive vision data. Extending that trust to AI features could normalize wearable tech in ways previous attempts failed.

If you wear prescription glasses and have been curious about AI assistants, these might be worth waiting for. The combination of familiar styling, prescription integration, and refined AI features addresses most complaints about current smart glasses.

However, early adopters should expect some kinks. First-generation prescription smart glasses will likely have fit issues and software bugs. The $100-200 premium over regular Ray-Bans might be better spent waiting for reviews and second-generation refinements.

For developers, the expanded user base of prescription wearers opens new possibilities for vision-based AI applications. The key question: will people who need glasses for daily life embrace additional AI features, or prefer to keep their eyewear simple?